Choroidal neovascular membrane complicating traumatic choroidal rupture managed by intravitreal bevacizumab

Abstract

Sir, Choroidal neovascular membrane complicating traumatic choroidal rupture managed by intravitreal bevacizumab

Intravitreal bevacizumab monotherapy in myopic choroidal neovascularisation: 5-year outcomes for the PAN-American Collaborative Retina Study Group

“…Contrary to the other non-AMD CNV, which occurs more commonly in young individuals,3 in the present study, the majority were in the above 50 years age group. Out of 31 patients, 17 (54.8%) were above 50 years, whereas 14/31 (45.16%) were below 50 years.…”

A Case of Expansion of Traumatic Choroidal Rupture with Delayed-Developed Outer Retinal Changes

“…A secondary CNV developing after ocular contusion trauma may be related to a rupture of Bruch's membrane, inflammatory response, and abnormal production of vascular endothelial growth factor. Many reports on the treatment of secondary CNV following choroidal rupture have been published [12, 13, 14, 15], and the present case experienced an improvement following an intravitreal bevacizumab injection.…”

Intravitreal bevacizumab for posttraumatic choroidal neovascularization in a child

“…3 Anti-VEGF therapy can therefore be an alternative treatment option for CNV related to traumatic choroidal rupture. [4][5][6][7][8] The use of bevacizumab for retinal vascular diseases, especially exudative age-related macular degeneration, is common in adults to treat subfoveal CNV. Recently this procedure has also been reported for vascular and inflammatory diseases in children.…”